Patent Number: 7,709,004

Title: Method of producing an HIV-1 immune response

Abstract: The present invention comprises novel and modified peptides capable of inducing an HIV-1 specific immune response without antagonizing the cytotoxic T-cell activity in order to achieve an effective prophylactic and therapeutic vaccine against HIV. The peptides are based on conserved regions of HIV gag p24 proteins. Antigens in free- or carrier-bound form comprising at least one of the said peptides, vaccine compositions containing at least one of the antigens, immunoassay kits and a method of detecting antibodies induced by HIV or HIV specific peptides using such antigens, are described.

Inventors: Sorensen; Birger (Skien, NO)

Assignee: Bionor Immuno AS

International Classification: A61K 39/38 (20060101); A61K 38/00 (20060101); G01N 33/53 (20060101); C12Q 1/70 (20060101); C12Q 1/00 (20060101); A61K 39/12 (20060101); A61K 39/21 (20060101)

Expiration Date: 5/04/12018